Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Metastatic Melanoma Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Metastatic Melanoma Drugmarket, defines the market attractiveness level of Metastatic Melanoma Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Metastatic Melanoma Drug industry, describes the types of Metastatic Melanoma Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Metastatic Melanoma Drug market and the development prospects and opportunities of Metastatic Melanoma Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Metastatic Melanoma Drug market in Chapter 13.
By Player:
NewLink Genetics Corporation
Merck & Co, Inc
Oncolytics Biotech Inc
Ono Pharmaceutical Co, Ltd
Novartis AG
Merck KGaA
Omeros Corporation
Morphotek, Inc
Philogen SpA
OncoSec Medical Inc
Millennium Pharmaceuticals, Inc
Pfizer Inc
Plexxikon Inc
Pharmis Biofarmaceutica, Lda
By Type:
AGI-134
ALT-801
ALT-803
AMG-232
Others
By End-User:
Hospital
Clinic
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Metastatic Melanoma Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Metastatic Melanoma Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Metastatic Melanoma Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Metastatic Melanoma Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Metastatic Melanoma Drug Market Analysis and Outlook to 2022
-
7.1 Global Metastatic Melanoma Drug Consumption (2017-2022)
-
7.2 United States Metastatic Melanoma Drug Consumption (2017-2022)
-
7.3 Europe Metastatic Melanoma Drug Consumption (2017-2022)
-
7.4 China Metastatic Melanoma Drug Consumption (2017-2022)
-
7.5 Japan Metastatic Melanoma Drug Consumption (2017-2022)
-
7.6 India Metastatic Melanoma Drug Consumption (2017-2022)
-
7.7 South Korea Metastatic Melanoma Drug Consumption (2017-2022)
8 Region and Country-wise Metastatic Melanoma Drug Market Analysis and Outlook to 2028
-
8.1 Global Metastatic Melanoma Drug Consumption Forecast (2022-2028)
-
8.2 United States Metastatic Melanoma Drug Consumption Forecast (2022-2028)
-
8.3 Europe Metastatic Melanoma Drug Consumption Forecast (2022-2028)
-
8.4 China Metastatic Melanoma Drug Consumption Forecast (2022-2028)
-
8.5 Japan Metastatic Melanoma Drug Consumption Forecast (2022-2028)
-
8.6 India Metastatic Melanoma Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Metastatic Melanoma Drug Consumption Forecast (2022-2028)
9 Global Metastatic Melanoma Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Metastatic Melanoma Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global AGI-134 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global ALT-801 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global ALT-803 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global AMG-232 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Metastatic Melanoma Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Metastatic Melanoma Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Metastatic Melanoma Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global AGI-134 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global ALT-801 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global ALT-803 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global AMG-232 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Metastatic Melanoma Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Metastatic Melanoma Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Metastatic Melanoma Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Metastatic Melanoma Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Metastatic Melanoma Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Metastatic Melanoma Drug Market Competitive Analysis
-
14.1 NewLink Genetics Corporation
-
14.1.1 NewLink Genetics Corporation Company Details
-
14.1.2 NewLink Genetics Corporation Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 NewLink Genetics Corporation Metastatic Melanoma Drug Product and Service
-
14.2 Merck & Co, Inc
-
14.2.1 Merck & Co, Inc Company Details
-
14.2.2 Merck & Co, Inc Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck & Co, Inc Metastatic Melanoma Drug Product and Service
-
14.3 Oncolytics Biotech Inc
-
14.3.1 Oncolytics Biotech Inc Company Details
-
14.3.2 Oncolytics Biotech Inc Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Oncolytics Biotech Inc Metastatic Melanoma Drug Product and Service
-
14.4 Ono Pharmaceutical Co, Ltd
-
14.4.1 Ono Pharmaceutical Co, Ltd Company Details
-
14.4.2 Ono Pharmaceutical Co, Ltd Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Ono Pharmaceutical Co, Ltd Metastatic Melanoma Drug Product and Service
-
14.5 Novartis AG
-
14.5.1 Novartis AG Company Details
-
14.5.2 Novartis AG Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis AG Metastatic Melanoma Drug Product and Service
-
14.6 Merck KGaA
-
14.6.1 Merck KGaA Company Details
-
14.6.2 Merck KGaA Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Merck KGaA Metastatic Melanoma Drug Product and Service
-
14.7 Omeros Corporation
-
14.7.1 Omeros Corporation Company Details
-
14.7.2 Omeros Corporation Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Omeros Corporation Metastatic Melanoma Drug Product and Service
-
14.8 Morphotek, Inc
-
14.8.1 Morphotek, Inc Company Details
-
14.8.2 Morphotek, Inc Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Morphotek, Inc Metastatic Melanoma Drug Product and Service
-
14.9 Philogen SpA
-
14.9.1 Philogen SpA Company Details
-
14.9.2 Philogen SpA Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Philogen SpA Metastatic Melanoma Drug Product and Service
-
14.10 OncoSec Medical Inc
-
14.10.1 OncoSec Medical Inc Company Details
-
14.10.2 OncoSec Medical Inc Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 OncoSec Medical Inc Metastatic Melanoma Drug Product and Service
-
14.11 Millennium Pharmaceuticals, Inc
-
14.11.1 Millennium Pharmaceuticals, Inc Company Details
-
14.11.2 Millennium Pharmaceuticals, Inc Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Millennium Pharmaceuticals, Inc Metastatic Melanoma Drug Product and Service
-
14.12 Pfizer Inc
-
14.12.1 Pfizer Inc Company Details
-
14.12.2 Pfizer Inc Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Pfizer Inc Metastatic Melanoma Drug Product and Service
-
14.13 Plexxikon Inc
-
14.13.1 Plexxikon Inc Company Details
-
14.13.2 Plexxikon Inc Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Plexxikon Inc Metastatic Melanoma Drug Product and Service
-
14.14 Pharmis Biofarmaceutica, Lda
-
14.14.1 Pharmis Biofarmaceutica, Lda Company Details
-
14.14.2 Pharmis Biofarmaceutica, Lda Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Pharmis Biofarmaceutica, Lda Metastatic Melanoma Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Metastatic Melanoma Drug
-
Figure Metastatic Melanoma Drug Picture
-
Table Global Metastatic Melanoma Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Metastatic Melanoma Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Metastatic Melanoma Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Metastatic Melanoma Drug Consumption by Country (2017-2022)
-
Figure United States Metastatic Melanoma Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Metastatic Melanoma Drug Consumption and Growth Rate (2017-2022)
-
Figure China Metastatic Melanoma Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Metastatic Melanoma Drug Consumption and Growth Rate (2017-2022)
-
Figure India Metastatic Melanoma Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Metastatic Melanoma Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Metastatic Melanoma Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Metastatic Melanoma Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Metastatic Melanoma Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Metastatic Melanoma Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Metastatic Melanoma Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Metastatic Melanoma Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Metastatic Melanoma Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AGI-134 Consumption and Growth Rate (2017-2022)
-
Figure Global ALT-801 Consumption and Growth Rate (2017-2022)
-
Figure Global ALT-803 Consumption and Growth Rate (2017-2022)
-
Figure Global AMG-232 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global AGI-134 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ALT-801 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ALT-803 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AMG-232 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Metastatic Melanoma Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Metastatic Melanoma Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table NewLink Genetics Corporation (Foundation Year, Company Profile and etc.)
-
Table NewLink Genetics Corporation Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table NewLink Genetics Corporation Metastatic Melanoma Drug Product and Service
-
Table Merck & Co, Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co, Inc Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co, Inc Metastatic Melanoma Drug Product and Service
-
Table Oncolytics Biotech Inc (Foundation Year, Company Profile and etc.)
-
Table Oncolytics Biotech Inc Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oncolytics Biotech Inc Metastatic Melanoma Drug Product and Service
-
Table Ono Pharmaceutical Co, Ltd (Foundation Year, Company Profile and etc.)
-
Table Ono Pharmaceutical Co, Ltd Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ono Pharmaceutical Co, Ltd Metastatic Melanoma Drug Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Metastatic Melanoma Drug Product and Service
-
Table Merck KGaA (Foundation Year, Company Profile and etc.)
-
Table Merck KGaA Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck KGaA Metastatic Melanoma Drug Product and Service
-
Table Omeros Corporation (Foundation Year, Company Profile and etc.)
-
Table Omeros Corporation Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Omeros Corporation Metastatic Melanoma Drug Product and Service
-
Table Morphotek, Inc (Foundation Year, Company Profile and etc.)
-
Table Morphotek, Inc Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Morphotek, Inc Metastatic Melanoma Drug Product and Service
-
Table Philogen SpA (Foundation Year, Company Profile and etc.)
-
Table Philogen SpA Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Philogen SpA Metastatic Melanoma Drug Product and Service
-
Table OncoSec Medical Inc (Foundation Year, Company Profile and etc.)
-
Table OncoSec Medical Inc Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table OncoSec Medical Inc Metastatic Melanoma Drug Product and Service
-
Table Millennium Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table Millennium Pharmaceuticals, Inc Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Millennium Pharmaceuticals, Inc Metastatic Melanoma Drug Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Metastatic Melanoma Drug Product and Service
-
Table Plexxikon Inc (Foundation Year, Company Profile and etc.)
-
Table Plexxikon Inc Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Plexxikon Inc Metastatic Melanoma Drug Product and Service
-
Table Pharmis Biofarmaceutica, Lda (Foundation Year, Company Profile and etc.)
-
Table Pharmis Biofarmaceutica, Lda Metastatic Melanoma Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pharmis Biofarmaceutica, Lda Metastatic Melanoma Drug Product and Service
-
